scholarly journals Synchronous Esophageal and Renal Malignancies with Unexpected Site of Metastasis: A Case Report

2020 ◽  
Vol 18 (2) ◽  
Author(s):  
Sharhanin Bahrudin

Introduction: Esophageal cancer is the fifth most common cancer in Asia. Synchronous malignancies with an esophageal malignancies is not uncommon however synchronous esophageal malignancy and renal cell carcinoma is rare. Case Report: A 70 years old non smoker man with comorbid of hypertension and diabetes mellitus presented with multiple episode of hemoptysis and pleuritic chest pain within one day duration. He also complaint of worsening dysphagia to solid food for 1 month duration with constitutional symptoms. Otherwise he does not have any other symptoms. Clinically he was pale and cachexic, otherwise all systemic examination was unremarkable. His blood investigation reveal low hemoglobin level of 9.9g/L with normal coagulation and renal profile. He underwent Oesophagoduodenoscopy which showed a tumor narrowing the lumen of the lower esophagus. Biopsy of the tumor revealed esophageal adenocarcinoma. CT thorax, abdomen and pelvis showed smooth circumferential wall thickening of the distal part of the esophagus near the gastroesophageal junction. Incidentally, there were heterogenous enhancing lobulated mass seen at the lower pole of left kidney with no obstructive uropathy features. Otherwise, others solid organ were normal. A left renal mass biopsy performed revealed renal cell carcinoma. An oncologist opinion was gathered for initiation of palliative chemotherapy however he developed symptomatic malignant pleural effusion which need a drainage. HRCT Thorax revealed multiple bilateral intrapulmonary nodule. He also complaint of a new right upper eyelid mass that increasing in size with contact bleeding however does not affect his visual. An assessment from an ophthalmologist and CT orbital performed consistent with features of a metastasis. Conclusion: Synchronous malignancies with an esophageal malignancies is not uncommon. Most common site reported is head and neck followed by lung malignancies. However synchronous esophageal malignancies and renal cell carcinoma is rare. Esophageal malignancies often have distant metastasis to the liver, lung and bone however rare to the eyelid.

2016 ◽  
Vol 9 (2) ◽  
pp. 58
Author(s):  
I. A. Broder ◽  
V. S. Nelaev ◽  
V. V. Prikhod’ko ◽  
L. A. Arutyunyan ◽  
A. V. Finkel ◽  
...  

2014 ◽  
Vol 8 (1) ◽  
Author(s):  
Yusuke Ishibashi ◽  
Takuya Koie ◽  
Naoki Fujita ◽  
Tendo Satoh ◽  
Jotaro Mikami ◽  
...  

2011 ◽  
Vol 11 ◽  
pp. 1173-1177 ◽  
Author(s):  
Michael S. Floyd ◽  
Saqib Javed ◽  
Keloth E. Pradeep ◽  
Alan R. De Bolla

We present the case of a 73-year-old woman who presented with lethargy and a nonproductive cough. Computerised tomography of her abdomen revealed a 38-mm mass in the lower pole of her left kidney. She underwent a partial nephrectomy, with final histopathological analysis confirming the presence of a concomitant oncocytoma and papillary cell carcinoma. To our knowledge, this is the only case report in the world literature describing a papillary renal cell carcinoma within an oncocytoma treated by partial nephrectomy.


2011 ◽  
Vol 9 (3-4) ◽  
pp. 0-0
Author(s):  
Albertas Ulys ◽  
Marius Markevičius ◽  
Mantas Trakymas ◽  
Narimantas Evaldas Samalavičius

Vilniaus universiteto Onkologijos instituto Onkochirurgijos centro II Onkochirurgijos skyriaus Onkourologijos poskyris, Santariškių g. 1, LT-08660 Vilnius El. paštas: [email protected] Mokslinės literatūros duomenimis, inkstų ląstelių karcinoma sudaro nuo 2% iki 3% visų suaugusiųjų piktybinių navikų. Tai yra apie 150 000 tūkstančių naujų atvejų pasaulyje kasmet, iš jų apie 700 susirgimų nustatoma Lietuvoje. Indikacijos atlikti radiodažnio abliaciją (RDA) yra: 1) vienintelio inksto karcinoma, kai rezekcija negalima, siekiant išvengti hemodializių, 2) abiejų inkstų navikai, kai dėl sunkios gretutinės patologijos radikali operacija negalima, 3) renoceliulinė karcinoma, išsivysčiusi transplantuotame inkste. Šiuo straipsniu norime apžvelgti įdomų klinikinį atvejį, kai 61 metų amžiaus ligonis atvyko į Vilniaus universiteto Onkologijos instituto Onkourologijos poskyrį gydytis dėl patikros metu rasto naviko dešiniajame inkste. Prieš trejus metus ligoniui dėl kairiojo inksto renoceliulinės karcinomos atlikta kairiojo inksto pašalinimo operacija. Radiodažnio abliacija – tai minimaliai invazinis vėžio gydymo metodas, kuris atliekamas įduriant specialų adatinį elektrodą į naviką, kontroliuojant procedūrą pagal vaizdą ultragarsinio aparato ekrane. Radiodažnio abliacijos (RDA) metodu mes gydome inkstų navikams, kontroliuodami procedūrą ultragarsu, naudodami kompiuterinės tomografijos ar magnetinio rezonanso navigaciją. Tai saugus ir patikimas, minimaliai invazinis inkstų navikų gydymo metodas, taikytinas ligoniams, sergantiems sunkiai kontroliuojamomis gretutinėmis ligomis, dėl kurių radikali operacija negalima ar kontraindikuojama. Pirmiausia pasirenkamu inkstų navikų gydymu išlieka inksto pašalinimo operacija. Norint įsitikinti RDA gydymo veiksmingumu ir saugumu, tikslinga atlikti daugiau ir platesnių tyrimų. Reikšminiai žodžiai: radiodažnio abliacija, renoceliulinė karcinoma, navikas. Radiofrequency ablation for renal malignancies: a case report Albertas Ulys, Marius Markevičius, Mantas Trakymas, Narimantas Evaldas Samalavičius Vilnius University Oncology Institute, Centre of Oncological Surgery, II Department of Oncological Surgery, Department of Oncological Urology, Santariškių Str. 1, LT-08660 Vilnius, Lithuania E-mail: [email protected] Renal cell carcinoma accounts for 2–3% of all cancers. A worldwide incidence of 150,000 cases of renal cell carcinoma (RCC) is estimated constituting approximately 2% of the malignancies in adults, in Lithuania it is found about 700 RCC per year. Indication for radiofrequency ablation (RFA) are the only kidney carcinoma, when resection is impossible, to prevent patient from hemodialisis, the elderly patients with comorbidities, the renal cell carcinoma in transplanted kidney. We report an interesting case report about 61 year old patient who came to our hospital with diagnosed renal cell carcinoma of right kidney. Three years ago, he went through left kidney nephrectomy, because of left side kidney renal carcinoma. Radiofrequency ablation (RFA) is a minimally invasive treatment modality that is made percutaneously with special electrode. Image-guided real-time ultrasound is used during operation, when radical treatment of renal cell carcinoma is diagnosed. It is safe and reliable treatment opportunity, for elderly patients that have many other disease and radical treatment is contraindicated. Gold standard for renal cell carcinoma is radical nephrectomy. More clinical investigations are needed to make sure about that treatment modality in the future to make that procedure more widely. Keywords: radiofrequency ablation, renocellular carcinoma, tumour.


2020 ◽  
Vol 47 (3) ◽  
pp. 18-21
Author(s):  
G. Yankov ◽  
V. Ilieva ◽  
B. Vladimirov ◽  
M. Kovacheva ◽  
E. Mekov ◽  
...  

AbstractGastroesophageal junction adenocarcinoma is a rare type of cancer of the esophagus. It is usually diagnosed in advanced stages and much less frequently in the earlier stage, where surgical treatment is essential. Surgical treatment is also essential in kidney cancer. The occurrence of synchronous malignancies with an esophageal malignancy is a well-described phenomenon with an incidence ranging from 3.6 to 27.1%. To the best of our knowledge, only 11 cases of synchronous esophageal and renal cell carcinoma (RCC) have been previously described. We present a patient operated simultaneously for cancer of the gastroesophageal junction with synchronous renal cell carcinoma. The finding in the kidney was accidentally discovered by the routine CT scan on the occasion of the relatively early carcinoma of the gastroesophageal junction detected by upper endoscopy. The patient was admitted to the Thoracic Surgery Department, where Ivor-Lewis gastroesophagoplasty and right nephrectomy simultaneously were performed. The patient was followed for 5 years without evidence of disease progression.


2004 ◽  
Vol 51 (3) ◽  
pp. 337
Author(s):  
Seung Hyun Cho ◽  
Young Hwan Lee ◽  
Kyung Jae Jung ◽  
Young Chan Park ◽  
Ho Kyun Kim ◽  
...  

2017 ◽  
Author(s):  
Carolina Faria ◽  
David Barbosa ◽  
Ana Sofia Osorio ◽  
Ema Nobre ◽  
Maria Joao Bugalho

2018 ◽  
Vol 25 (1) ◽  
pp. 30-33
Author(s):  
B.B. Bantysh ◽  
◽  

Sign in / Sign up

Export Citation Format

Share Document